MedPath

Glucose-insulin-potassium infusion in patients treated with primary percutaneous coronary intervention for acute myocardial infarctio

Completed
Conditions
ST elevation myocardial infarction (mi)
Circulatory System
Acute myocardial infarction
Registration Number
ISRCTN56720616
Lead Sponsor
etherlands Heart Foundation (Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
940
Inclusion Criteria

All consecutive patients with symptoms consistent with acute MI of >30 min duration, presenting within 24 hours after the onset of symptoms and with an ST-segment elevation of more than 1 mm (0.1 mV) in two or more contiguous leads on the electrocardiogram, or new onset left bundle branch block, were evaluated for inclusion in this single-center study. Patients presented at our center and patients referred for treatment of high-risk myocardial infarction (MI) from nine referring hospitals without angioplasty facilities were included.

Exclusion Criteria

Patients were excluded when pre-treated with thrombolysis or when an illness associated with a marked restricted life expectancy was present.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
30-day mortality
Secondary Outcome Measures
NameTimeMethod
Recurrent infarction, repeat coronary angioplasty, and the composite incidence of death, recurrent infarction, or repeat coronary angioplasty.
© Copyright 2025. All Rights Reserved by MedPath